Dapas B, Dall'Acqua S, Bulla R, Agostinis C, Perissutti B, Invernizzi S, Grassi G, Voinovich D
Department of Life Sciences, Cattinara Hospital, University of Trieste, Strada di Fiume 447, Trieste, Italy.
Department of Pharmaceutical Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy.
Phytomedicine. 2014 Sep 25;21(11):1406-10. doi: 10.1016/j.phymed.2014.04.034. Epub 2014 May 28.
In this study, the immunomodulatory effect of a triply standardized Echinacea angustifolia root extract (Polinacea(®)) was evaluated in 10 healthy subjects. Ten ml of syrup containing one hundred mg of extract (corresponding to 4.7 mg of Echinacoside and 8.0mg of a high molecular weight-20,000 Da- polysaccharide) were administered as a herbal syrup once a day for one month. The immunomodulatory effect was evaluated before and after herbal syrup administration evaluating the expression levels of the cytokines IL-2, IL-8, IL-6 and TNF-α. Cytokine expression was studied in lympho-monocytes and in plasma samples measuring the mRNA and protein levels, respectively. The results were analysed by ANOVA and non-parametric Friedman rank sum tests; when possible it was adopted a pair-wise comparisons at different post-treatment times, using the paired t-tests with Holm correction. The correlation between the variations of cytokine plasma levels and the respective mRNA was carried out using a linear regression model. In lympho-monocytes our data indicate the up-regulation of the mRNA levels of IL-2 and IL-8 and the down regulation of the mRNA levels of the pro-inflammatory cytokines TNF-α and IL6. The differential regulation was maximal after 14 days of treatment. IL-2 up-regulation and IL-6 down-regulation were also confirmed at the protein level in plasma. Finally, the up-regulation of the mRNA of IL-2/IL-8 and the down-regulation of IL-6 positively correlated with the protein levels detected in the plasma. In conclusion, this pilot study suggests a relevant role for the standardized Echinacea angustifolia root extract in the control of cytokine expression. This first demonstration of the immuno-modulating activity of Echinacea angustifolia root extract in the healthy subject, supports at least in part the common use of such products as health promoting supplement.
在本研究中,对10名健康受试者评估了三重标准化紫锥菊根提取物(Polinacea(®))的免疫调节作用。每天一次给予10毫升含有100毫克提取物的糖浆(相当于4.7毫克紫锥菊苷和8.0毫克分子量为20,000道尔顿的高分子量多糖)作为草药糖浆,持续一个月。在给予草药糖浆前后,通过评估细胞因子IL-2、IL-8、IL-6和TNF-α的表达水平来评估免疫调节作用。分别在淋巴细胞和血浆样本中研究细胞因子表达,测量mRNA和蛋白质水平。结果通过方差分析和非参数Friedman秩和检验进行分析;在可能的情况下,在不同治疗后时间采用配对t检验并进行Holm校正进行两两比较。使用线性回归模型分析细胞因子血浆水平变化与各自mRNA之间的相关性。在淋巴细胞中,我们的数据表明IL-2和IL-8的mRNA水平上调,促炎细胞因子TNF-α和IL-6的mRNA水平下调。治疗14天后差异调节最大。血浆中蛋白质水平也证实了IL-2上调和IL-6下调。最后,IL-2/IL-8的mRNA上调和IL-6下调与血浆中检测到的蛋白质水平呈正相关。总之,这项初步研究表明标准化紫锥菊根提取物在控制细胞因子表达方面具有重要作用。紫锥菊根提取物在健康受试者中免疫调节活性的首次证明,至少部分支持了此类产品作为健康促进补充剂的普遍使用。